Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world prostate-specific antigen response and progression to castration-resistant prostate cancer among men with metastatic castration-sensitive prostate cancer treated with apalutamide: a multi-institutional study in the Chu-shikoku Japan Urological Consortium.
Tohi Y, Kato T, Kobayashi K, Daizumoto K, Fukuhara H, Ohira S, Katayama S, Shimizu R, Takamoto A, Nishimura K, Ikeda K, Nagami T, Hayashida Y, Hirama H, Naito H, Tomida R, Sasaki Y, Yamamoto S, Shimizu S, Sugimoto M; Chu-shikoku Japan Urological Consortium. Tohi Y, et al. Among authors: ikeda k. Jpn J Clin Oncol. 2024 Feb 7;54(2):167-174. doi: 10.1093/jjco/hyad143. Jpn J Clin Oncol. 2024. PMID: 37840362
Real-world analysis of apalutamide-associated skin adverse events in Japanese patients with advanced prostate cancer: a multi-institutional study in the Chu-shikoku Japan Urological Consortium.
Tohi Y, Kato T, Fukuhara H, Kobayashi K, Ohira S, Ikeda K, Daizumoto K, Katayama S, Shimizu R, Nishimura K, Nagami T, Hayashida Y, Hirama H, Takamoto A, Dainichi T, Sugimoto M; Chu-shikoku Japan Urological Consortium. Tohi Y, et al. Among authors: ikeda k. Int J Clin Oncol. 2022 Aug;27(8):1348-1355. doi: 10.1007/s10147-022-02183-z. Epub 2022 May 20. Int J Clin Oncol. 2022. PMID: 35596089
Real-world treatment patterns and outcomes in Japanese patients with cervical esophageal cancer.
Ohno K, Nasu M, Matsui H, Baba Y, Yasuda T, Sakuma J, Ikeda K, Maruo T, Okuda T, Narita N, Kato H, Kawasaki T, Sato H, Tokashiki K, Akisada N, Ishinaga H, Akashi K, Okami K, Murayama K, Yamamoto S, Kumakura Y, Kawada K, Shiotani A, Asakage T. Ohno K, et al. Among authors: ikeda k. Esophagus. 2022 Oct;19(4):576-585. doi: 10.1007/s10388-022-00921-w. Epub 2022 May 7. Esophagus. 2022. PMID: 35525856
Dynamic microvilli sculpt bristles at nanometric scale.
Ikeda KN, Belevich I, Zelaya-Lainez L, Orel L, Füssl J, Gumulec J, Hellmich C, Jokitalo E, Raible F. Ikeda KN, et al. Nat Commun. 2024 May 13;15(1):3733. doi: 10.1038/s41467-024-48044-3. Nat Commun. 2024. PMID: 38740737 Free PMC article.
Development of a laparoscopic sigmoidectomy simulator: Sigmaster.
Shigaki T, Hasegawa H, Teramura K, Takeshita N, Ikeda K, Tsukada Y, Nishizawa Y, Sasaki T, Ito M. Shigaki T, et al. Among authors: ikeda k. Surg Today. 2024 May 14. doi: 10.1007/s00595-024-02855-5. Online ahead of print. Surg Today. 2024. PMID: 38740574
Long-term Favorable Efficacy of Regular and Repeated Hospitalizations with a Personalized Diet and Exercise Treatment for Steatotic Liver Disease.
Akuta N, Kawamura Y, Sezaki H, Nakamichi K, Saegusa E, Ogura H, Kato M, Doi E, Inoue N, Hosaka T, Saitoh S, Kobayashi M, Fujiyama S, Arase Y, Ikeda K, Suzuki Y, Kumada H, Suzuki F. Akuta N, et al. Among authors: ikeda k. Intern Med. 2024 May 9. doi: 10.2169/internalmedicine.3650-24. Online ahead of print. Intern Med. 2024. PMID: 38719593 Free article.
7,103 results